20
Participants
Start Date
July 24, 2019
Primary Completion Date
February 14, 2025
Study Completion Date
February 14, 2025
Carevive software
In this study, Carevive will deliver a link to subjects so that an online survey can be completed. The survey will occur weekly for the first 12 weeks of the study and will be spaced out to every other week thereafter. The questions will mostly focus on side effects from their cancer therapy, as well as a few questions about drug compliance and healthcare utilization. After completion of the survey, the subject will be given a care plan with at home self-management options for drug-related toxicities.
University of Rochester - Wilmot Cancer Institute, Rochester
National Cancer Institute (NCI)
NIH
University of Rochester
OTHER